Product image of Idilla (Dienogest, Estradiol Valerate) supplied by GNH India

Idilla

Active Ingredient:
Dienogest, Estradiol Valerate
Origin:
EU

Idilla (Dienogest, Estradiol Valerate)

Dienogest/Estradiol Valerate, the active ingredient in Idilla, is a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception and helps regulate the menstrual cycle in women of reproductive age.

GNH India supplies Idilla as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Farmitalia S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Idilla, a combined oral contraceptive, is used to manage hormonal contraception and menstrual cycle regulation.

  • Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus.
  • Menstrual cycle regulation: Reduces irregular bleeding and stabilises cycle length.
  • Endometriosis‑related pain: Alleviates pain associated with endometriosis by suppressing estrogen‑driven tissue growth.

How It Works

  • Idilla combines a progestogen (dienogest) with an estrogen (estradiol valerate) to suppress the hypothalamic‑pituitary‑ovarian axis, preventing the mid‑cycle surge of luteinising hormone and thereby inhibiting ovulation. The progestogen also thickens cervical mucus and induces endometrial changes that reduce the likelihood of fertilisation and implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: temporary swelling or discomfort.
  • Spotting or breakthrough bleeding: irregular light bleeding.
  • Weight change: slight increase or decrease.
  • Mood changes: irritability or mild depressive symptoms.

Serious or Rare Side Effects

  • Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
  • Stroke or transient ischaemic attack.
  • Myocardial infarction: heart attack risk, especially in smokers.
  • Severe allergic reaction: anaphylaxis, rash, or angioedema.
  • Liver dysfunction: jaundice or abnormal liver enzymes.
  • Hyperglycaemia: elevated blood sugar in susceptible individuals.

Precautions & Warnings

Before prescribing Idilla, clinicians should evaluate individual risk factors and contraindications.

  • Pregnancy: contraindicated (Category X); do not use during pregnancy.
  • Smoking: avoid in women over 35 who smoke due to increased cardiovascular risk.
  • Cardiovascular disease: assess history of thromboembolism, stroke, or myocardial infarction.
  • Liver disease: use with caution in patients with hepatic impairment.
  • Migraine with aura: avoid because of heightened stroke risk.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Idilla may interact with several medicines that alter hormone metabolism or clotting pathways.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): markedly reduce contraceptive efficacy.
  • Anticoagulants (e.g., warfarin): may increase risk of thrombosis.
  • Certain antiepileptics (e.g., phenytoin): decrease hormone levels, compromising contraception.

Moderate Interactions (Monitor Closely)

  • Antibiotics such as tetracycline or metronidazole: possible modest reduction in effectiveness.
  • Herbal supplements (e.g., St. John's wort): may lower plasma hormone concentrations.
  • Antifungal agents (e.g., ketoconazole): can raise hormone levels, increasing side‑effect risk.

Frequently Asked Questions

Idilla is a prescription combined oral contraceptive that provides reliable birth control and helps regulate irregular menstrual cycles. It is also employed in the management of estrogen‑dependent conditions such as endometriosis‑related pain.

The progestogen dienogest suppresses the luteinising hormone surge, preventing ovulation, while estradiol valerate supplies a stable estrogen level. Together they thicken cervical mucus and alter the endometrium, creating an environment that is unfavourable for fertilisation and implantation.

The dosing regimen for Idilla is determined by the prescribing clinician based on the product’s labeling and the patient’s individual needs. Patients should follow the prescriber’s instructions and not alter the schedule without medical advice.

Idilla is classified as Pregnancy Category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as hormonal exposure may affect milk production and infant health.

To order Idilla, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Idilla combines dienogest, a third‑generation progestogen with a favourable bleeding profile, and estradiol valerate, an estrogen that mimics natural estradiol. Compared with older formulations that use ethinyl‑estradiol, Idilla may offer a more physiological estrogen exposure and potentially lower risk of estrogen‑related side effects.

Idilla tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Idilla is taken orally once daily, preferably at the same time each day, with or without food. The typical regimen follows a 21‑day active tablet sequence followed by a 7‑day hormone‑free interval, during which withdrawal bleeding occurs.

The most serious risks include venous thromboembolism, stroke, myocardial infarction, and severe allergic reactions. Women with a history of clotting disorders, cardiovascular disease, smoking over age 35, or migraine with aura should avoid using Idilla.

Idilla is contraindicated in pregnant women, individuals with known or suspected breast cancer, active liver disease, uncontrolled hypertension, a history of thromboembolic events, and smokers over 35 years of age. It should also be avoided in women with migraine with aura.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dienogest, Estradiol Valerate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT